It was reported that EGFR triggers endoplasmic reticulum stress and activates the UPR pathway through downstream signaling pathways such as RAS/MAPK and PI3K/AKT, inhibiting cell apoptosis and promoting tumor cell survival and drug resistance [63]. Here, EGFR is linked to neoplasm.